Harold H. Shlevin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 30,000 shares at $5.00 ($151K) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($151k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 7,732 | $39K | 25.6% |
| 2 | $5.04 | 22,268 | $112K | 74.4% |
| Total | $5.03 avg | 30,000 | $151K | 100% |
| Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |
| GALT | SELL | 2018-06-14 | $565K | — | Filing → |